P. Plagemann

P. Plagemann, H. Swim, M. Watanabe, 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age.

J. Harty, R. Rowland, G. Palmer, 1995, Journal of neurovirology.

Differential glycosylation of the ectodomain of the primary envelope glycoprotein of two strains of lactate dehydrogenase-elevating virus that differ in neuropathogenicity.

G. Palmer, K. Faaberg, P. Plagemann, 1995, Virus research.

Monoclonal antibody protection from age-dependent poliomyelitis: implications regarding the pathogenesis of lactate dehydrogenase-elevating virus

J. Harty, P. Plagemann, 1990, Journal of virology.

Growth of Novikoff rat hepatoma cells in suspension culture in the presence of adenosine 3',5'-cyclic monophosphate.

P. Plagemann, J. Schröder, 1971, Journal of the National Cancer Institute.

An improved enzymatic radioassay for ribose 1-phosphate.

R. McIvor, R. Wohlhueter, P. Plagemann, 1982, Analytical biochemistry.

The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus.

P. Plagemann, 2004, Veterinary immunology and immunopathology.

Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus.

P. Plagemann, 2001, Virology.

Neuropathogenicity and susceptibility to immune response are interdependent properties of lactate dehydrogenase-elevating virus (LDV) and correlate with the number of N-linked polylactosaminoglycan chains on the ectodomain of the primary envelope glycoprotein.

R. Rowland, Z. Chen, P. Plagemann, 1998, Advances in experimental medicine and biology.

Neutralizing antibody formation in swine infected with seven strains of porcine reproductive and respiratory syndrome virus as measured by indirect ELISA with peptides containing the GP5 neutralization epitope.

P. Plagemann, 2006, Viral immunology.

Peptide ELISA for measuring antibodies to N-protein of porcine reproductive and respiratory syndrome virus.

P. Plagemann, 2006, Journal of virological methods.

Epitope specificity of monoclonal antibodies to the N-protein of porcine reproductive and respiratory syndrome virus determined by ELISA with synthetic peptides.

P. Plagemann, 2005, Veterinary immunology and immunopathology.

Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice.

R. Rowland, Z. Chen, P. Plagemann, 1999, Journal of neurovirology.

Lactate dehydrogenase-elevating virus (LDV): subgenomic mRNAs, mRNA leader and comparison of 3'-terminal sequences of two LDV isolates

R. Rowland, K. Faaberg, P. Plagemann, 1992, Virus Research.

Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein.

Z. Chen, P. Plagemann, K. Li, 2000, Virology.

The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein.

Z. Chen, P. Plagemann, K. Li, 1998, Virology.

Replication competition between lactate dehydrogenase-elevating virus quasispecies in mice. Implications for quasispecies selection and evolution

Z. Chen, P. Plagemann, K. Li, 2001, Archives of Virology.

N-glycans on the short ectodomain of the primary envelope glycoprotein play a major role in the polyclonal activation of B cells by lactate dehydrogenase-elevating virus.

W. Cafruny, P. Plagemann, Q. Jones, 2000, Journal of General Virology.

Isolation of lactate dehydrogenase-elevating viruses from wild house mice and their biological and molecular characterization.

G. Glass, J. Childs, Z. Chen, 2000, Virus research.

Lactate dehydrogenase-elevating virus variants: cosegregation of neuropathogenicity and impaired capability for high viremic persistent infection.

R. Rowland, Z. Chen, P. Plagemann, 1998, Journal of neurovirology.

Lactate dehydrogenase-elevating virus variants

R. Rowland, P. Plagemann, G. W. Anderson, 1998 .

The Coronaviridae now comprises two genera, coronavirus and torovirus: report of the Coronaviridae Study Group.

M. Lai, Marian C. Horzinek, L. Enjuanes, 1993, Advances in experimental medicine and biology.

Immune response to lactate dehydrogenase-elevating virus: serologically specific rabbit neutralizing antibody to the virus

W. Cafruny, P. Plagemann, 1982, Infection and immunity.

ORF 3 of lactate dehydrogenase-elevating virus encodes a soluble, nonstructural, highly glycosylated, and antigenic protein.

K. Faaberg, P. Plagemann, 1997, Virology.

Characteristics of monoclonal antibodies to the lactate dehydrogenase-elevating virus.

J. Harty, P. Plagemann, S. Chan, 1987, Intervirology.

Polyclonal activation of B cells by lactate dehydrogenase-elevating virus is mediated by N-glycans on the short ectodomain of the primary envelope glycoprotein.

W. Cafruny, P. Plagemann, Q. Jones, 2001, Advances in experimental medicine and biology.

Purification of mengovirus and identification of an A-rich segment in its ribonucleic acid.

R. Miller, P. Plagemann, 1972, The Journal of general virology.

Symposium on replication of viral nucleic acids. 3. Replication of mengovirus ribonucleic acid

P. Plagemann, H. Swim, 1966 .

Actinomycin D cytotoxicity for mouse peritoneal macrophages and effect on lactate dehydrogenase-elevating virus replication.

M. Brinton, P. Plagemann, 1980, Intervirology.

Hexose transport and phosphorylation by Novikoff rat hepatoma cells as function of extracellular pH.

R. Wohlhueter, P. Plagemann, 1981, The Journal of biological chemistry.

Membrane association of the C-terminal half of the open reading frame 1a protein of lactate dehydrogenase-elevating virus

K. Faaberg, P. Plagemann, 2005, Archives of Virology.

Cyclic 3',5'-nucleotide phosphodiesterases of Novikoff rat hepatoma, mouse L, and HeLa cells growing in suspension culture.

P. Plagemann, J. Schröder, 1972, Cancer research.

Uridine phosphorylase from Novikoff rat hepatoma cells: Purification, kinetic properties, and its role in uracil anabolism

R. McIvor, R. Wohlhueter, P. Plagemann, 1985, Journal of cellular physiology.

Broad specificity hexose transport system with differential mobility of loaded and empty carrier, but directional symmetry, is common property of mammalian cell lines.

R. Wohlhueter, P. Plagemann, J. Erbe, 1981, Journal of Biological Chemistry.

Revision of the taxonomy of theCoronavirus, Torovirus andArterivirus genera

M. Lai, Marian C. Horzinek, L. Enjuanes, 1994, Archives of Virology.

Relationship Between the Lactic Dehydrogenase-Elevating Virus and Transplantable Murine Tumors.∗

P. Plagemann, H. Swim, 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

CYTOCHALASIN B

P. Plagemann, R. Estensen, 1972, The Journal of cell biology.

On the mechanism of phenethyl alcohol-induced loss of polyribosomes and their re-formation after reversal in rat hepatoma cells.

P. Plagemann, 1968, Journal of Biological Chemistry.

Genomic differences between strains of lactate dehydrogenase-elevating virus.

C. Contag, E. Retzel, P. Plagemann, 1986, Intervirology.

Permeation and salvage of dideoxyadenosine in mammalian cells.

C. Woffendin, P. Plagemann, 1989, Molecular pharmacology.